| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |